{"entity":{"type":"insider","cik":"0001459477","url":"/insider/0001459477","json_url":"/insider/0001459477.json","name":"Kalnik Matthew W.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":9,"first":"2009-11-18","last":"2011-04-05","span_basis":"filed_date"},"name_variants":[{"name":"Kalnik Matthew W.","source":"filing","n_filings":9,"first_seen":"2009-11-18","last_seen":"2011-04-05"}],"transactions":[{"id":8970650,"accession":"0001455244-11-000019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001455244-11-000019","line_url":"/filing/0001455244-11-000019#line-2","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001459477","owner_name":"Kalnik Matthew W.","owner_display_name":"Kalnik Matthew W.","owner_url":"/insider/0001459477","role":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark":"O","role_mark_label":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategic Plan. & Bus. Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6300.0,"shares_display":"6,300","price_per_share":5.7984,"price_display":"5.80","price_state":"stated","total_value":36529.92,"total_display":"36,529.92","total_whole":"36,530","shares_owned_after":41050.0,"shares_owned_after_display":"41,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-01","filed_date":"2011-04-05","scope":"insider"},{"id":7205488,"accession":"0001455244-10-000120","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001455244-10-000120","line_url":"/filing/0001455244-10-000120#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001459477","owner_name":"Kalnik Matthew W.","owner_display_name":"Kalnik Matthew W.","owner_url":"/insider/0001459477","role":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark":"O","role_mark_label":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategic Plan. & Bus. Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":5.78,"price_display":"5.78","price_state":"stated","total_value":8670.0,"total_display":"8,670.00","total_whole":"8,670","shares_owned_after":44225.1037,"shares_owned_after_display":"44,225.10","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-26","filed_date":"2010-07-27","scope":"insider"},{"id":7312810,"accession":"0001455244-10-000118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001455244-10-000118","line_url":"/filing/0001455244-10-000118#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001459477","owner_name":"Kalnik Matthew W.","owner_display_name":"Kalnik Matthew W.","owner_url":"/insider/0001459477","role":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark":"O","role_mark_label":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategic Plan. & Bus. Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1625.0,"shares_display":"1,625","price_per_share":5.48,"price_display":"5.48","price_state":"stated","total_value":8905.0,"total_display":"8,905.00","total_whole":"8,905","shares_owned_after":45725.1037,"shares_owned_after_display":"45,725.10","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-19","filed_date":"2010-07-21","scope":"insider"},{"id":7572758,"accession":"0001455244-10-000095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001455244-10-000095","line_url":"/filing/0001455244-10-000095#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001459477","owner_name":"Kalnik Matthew W.","owner_display_name":"Kalnik Matthew W.","owner_url":"/insider/0001459477","role":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark":"O","role_mark_label":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategic Plan. & Bus. Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":5.78,"price_display":"5.78","price_state":"stated","total_value":13005.0,"total_display":"13,005.00","total_whole":"13,005","shares_owned_after":47350.1037,"shares_owned_after_display":"47,350.10","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-13","filed_date":"2010-04-15","scope":"insider"},{"id":7330519,"accession":"0001455244-10-000091","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001455244-10-000091","line_url":"/filing/0001455244-10-000091","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001459477","owner_name":"Kalnik Matthew W.","owner_display_name":"Kalnik Matthew W.","owner_url":"/insider/0001459477","role":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark":"O","role_mark_label":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategic Plan. & Bus. Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1950.0,"shares_display":"1,950","price_per_share":5.483846153846154,"price_display":"5.48","price_state":"stated","total_value":10693.5,"total_display":"10,693.50","total_whole":"10,694","shares_owned_after":51700.1037,"shares_owned_after_display":"51,700.10","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-01","filed_date":"2010-04-05","scope":"insider","n_lines":3},{"id":7766344,"accession":"0001455244-10-000071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001455244-10-000071","line_url":"/filing/0001455244-10-000071#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001459477","owner_name":"Kalnik Matthew W.","owner_display_name":"Kalnik Matthew W.","owner_url":"/insider/0001459477","role":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark":"O","role_mark_label":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategic Plan. & Bus. Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9873.0,"shares_display":"9,873","price_per_share":5.93,"price_display":"5.93","price_state":"stated","total_value":58546.89,"total_display":"58,546.89","total_whole":"58,547","shares_owned_after":29650.1037,"shares_owned_after_display":"29,650.10","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-17","filed_date":"2010-03-17","scope":"insider"},{"id":7250122,"accession":"0001455244-10-000069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001455244-10-000069","line_url":"/filing/0001455244-10-000069#line-2","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001459477","owner_name":"Kalnik Matthew W.","owner_display_name":"Kalnik Matthew W.","owner_url":"/insider/0001459477","role":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark":"O","role_mark_label":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategic Plan. & Bus. Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1125.0,"shares_display":"1,125","price_per_share":5.95,"price_display":"5.95","price_state":"stated","total_value":6693.75,"total_display":"6,693.75","total_whole":"6,694","shares_owned_after":39523.1037,"shares_owned_after_display":"39,523.10","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-11","filed_date":"2010-03-17","scope":"insider"},{"id":7168002,"accession":"0001455244-10-000034","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001455244-10-000034","line_url":"/filing/0001455244-10-000034#line-3","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001459477","owner_name":"Kalnik Matthew W.","owner_display_name":"Kalnik Matthew W.","owner_url":"/insider/0001459477","role":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark":"O","role_mark_label":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategic Plan. & Bus. Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":12262.5,"total_display":"12,262.50","total_whole":"12,263","shares_owned_after":39523.1037,"shares_owned_after_display":"39,523.10","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-02","filed_date":"2010-03-04","scope":"insider"},{"id":5684947,"accession":"0001455244-09-000119","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001455244-09-000119","line_url":"/filing/0001455244-09-000119","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001459477","owner_name":"Kalnik Matthew W.","owner_display_name":"Kalnik Matthew W.","owner_url":"/insider/0001459477","role":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark":"O","role_mark_label":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategic Plan. & Bus. Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6900.0,"shares_display":"6,900","price_per_share":4.970289855072464,"price_display":"4.97","price_state":"stated","total_value":34295.0,"total_display":"34,295.00","total_whole":"34,295","shares_owned_after":31118.8218,"shares_owned_after_display":"31,118.82","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-17","filed_date":"2009-11-18","scope":"insider","n_lines":2},{"id":5684945,"accession":"0001455244-09-000119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001455244-09-000119","line_url":"/filing/0001455244-09-000119#line-1","is_derivative":false,"issuer_cik":"0000072444","issuer_name":"NABI BIOPHARMACEUTICALS","issuer_ticker":"NABI","issuer_name_source":null,"issuer_url":"/issuer/0000072444","owner_cik":"0001459477","owner_name":"Kalnik Matthew W.","owner_display_name":"Kalnik Matthew W.","owner_url":"/insider/0001459477","role":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark":"O","role_mark_label":"Officer (SVP Strategic Plan. & Bus. Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategic Plan. & Bus. Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7674.0,"shares_display":"7,674","price_per_share":4.4743,"price_display":"4.47","price_state":"stated","total_value":34335.7782,"total_display":"34,335.78","total_whole":"34,336","shares_owned_after":38018.8218,"shares_owned_after_display":"38,018.82","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-11-16","filed_date":"2009-11-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000072444","name":"NABI BIOPHARMACEUTICALS","url":"/issuer/0000072444","role":"Officer (SVP Strategic Plan. & Bus. Ops)","n_filings":9,"first_seen":"2009-11-18","last_seen":"2011-04-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001459477","retrieved_at":"2026-08-22T07:07:14+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}